Ads
related to: fda
Search results
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
FierceBiotech· 10 hours agoThe docs for Eli Lilly’s donanemab advisory committee meeting are in: the FDA has raised concerns...
FDA rescinds marketing ban on Juul vaping products – KION546
KION 46 Salinas· 7 hours agoJuul said Thursday its products will remain on the market during scientific review. In 2022, the FDA...
FDA Advisors Recommend Against Using MDMA for PTSD Treatment
Time via Yahoo News· 1 day agoCredit - Getty Images/Image Source A panel of experts advising the U.S. Food and Drug Administration...
FDA panel OKs new COVID vaccine for fall
Medical Xpress· 8 hours agoThe FDA is expected to formally recommend a new variant target for vaccine makers in the coming weeks, the Times reported. Dr. Peter Marks, who oversees...
US FDA Rescinds Market Denial Order for Juul Products
US News & World Report· 9 hours agoThe latest move comes a few months after Juul sought an FDA authorization for new menthol-flavored pods meant to be used with its e-cigarette device, which was under the agency's ...
FDA Rescinds Juul Ban, Opening Door for Federal Clearance
The Wall Street Journal· 10 hours agoThe agency hasn’t yet reached a final determination on whether they can stay on the U.S. market, but...
FDA Panel OKs New COVID Vaccine for Fall | FOX 28 Spokane
FOX 28 Spokane· 12 hours agoFood and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID...
The FDA reverses ban on Juul e-cigarettes
AOL· 8 hours agoThe Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape ...
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
Reason.com via Yahoo News· 1 day agoMAPS Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock...
U.S. FDA places clinical hold on Biomea's diabetes trials
AOL· 4 hours agoThe drug developer said the FDA cited deficiencies based on the level of possible drug-induced toxic liver disease observed in the completed dose escalation phase of the trial ...
